Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
advisory, analytical, autoimmune, AutoVac, binding, BioxomeTM, body, built, cancer, cGMP, consent, consummation, deadline, direct, disposition, Earnout, EBITDA, enterprise, entry, expense, fail, final, formalized, framework, greater, group, heading, healthcare, implying, incontinence, intercompany, IPO, iv, Lab, Liability, Metalmarket, month, Neumann, Notwithstanding, obtain, ourself, output, PIPE, Pluripotent, predominantly, proprietary, protective, reimbursement, rejection, release, Restated, Ricky, RRA, sector, source, SPA, SRI, streamline, therefrom, transform, twelve, unified, unmet, UPA, urinary, virtually, waiver
Removed:
ATMP, capacity, CGT, collaboration, combined, continuing, distributed, distribution, ensured, expectation, grow, harmonization, industrial, institution, leverage, manpower, OMPUL, practically, promising, purpose, reliable, replication, rolling, safe, segment, solution, stage, standardized, trade, validate, validation, worked
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view